Mission, vision and strategy

Statens Serum Institut prevents and controls infectious diseases, biological threats and congenital diseases.

Mission

We strengthen health through disease control and research.

Vision

SSI is an integrated part of the Danish and international healthcare system and translates research into future preparedness.

SSI ensures this preparedness through the following activities:

  • Surveillance and prevention of infectious diseases and biological threats
  • Screening of all newborns for congenital disorders to reduce the harm from these disorders
  • Specialized and preparedness-related diagnostics and reference laboratories in the biomedical field
  • Ensuring supply of vaccines and preparedness products for the Danish vaccine programmes and infectious disease preparedness
  • High quality, internationally recognized research to strengthen surveillance, diagnostics, treatment and prevention of diseases
  • Operation of the Danish National Biobank and related health registers
  • Preparations to take over national veterinary preparedness in 2020 in collaboration with the University of Copenhagen, as part of an integrated ‘One Health’ approach

Strategic priority areas

SSI aims to strengthen the following main strategic areas:

  • Infectious disease preparedness through continued digitalization, development of microbiological and epidemiological methods, and analyses of the burden of disease and the economics of healthcare, through interdisciplinary collaborations
  • Laboratory-based infectious disease preparedness, through research and application of new microbiology techniques
  • Surveillance and prevention of infectious disease and antimicrobial resistance
  • Research based on biobanked material and register data, through the linkage of genetics, immunology, biomedicine and epidemiology, with a focus on personalized medicine and precision public health
  • Development and improvement of specialized diagnostics for congenital disorders
  • Ensuring supply of vaccines for the Danish vaccine programmes after the divestment of SSI’s in-house vaccine production and against the background of the current global vaccine shortage
  • Vaccine research to understand the mechanisms of action and side effects of vaccines and thereby contribute to Danish vaccine preparedness and to the development of new vaccines
  • SSI’s international profile in international organizations (e.g. EU, WHO) and in research
  • Adopting the ‘One Health’ approach to all our tasks, including preparing to take over leadership of national veterinary preparedness (in collaboration with the University of Copenhagen) and integrating this new area of responsibility into SSI’s other preparedness activities

Five qualities we strive for

SSI strives hard to fulfill our mission, vision and strategy. To do this, we have identified five qualities that will help us stay on the right path. These qualities capture what we expect from ourselves and what the outside world can expect from SSI.

We strengthen health through disease control and research.

SSI strives hard to fulfill our mission, vision and strategy. To do this, we have identified five qualities that will help us stay on the right path. The five qualities capture what we expect from ourselves and what the outside world can expect from SSI.

PREPARED
As a preparedness organization, SSI is ready for the unknown and capable of taking swift and effective action to counter concrete threats, be they infectious diseases, congenital disorders or other threats, through our specialized competencies, activities and research.

PROFESSIONAL
Professionalism secures SSI’s credibility and is a prerequisite for all of SSI’s activities, and ensures the best and most correct solutions. Our high degree of professionalism also ensures that the outside world may expect high quality solutions from the Institute.
The evidence and research-based foundation of our activities is a cornerstone of our professionalism.

BENEFICIAL
As a public institution SSI is obligated to contribute significantly to the good of Danish and international society, including e.g. the Danish healthcare system, the Danish public, international organizations and the Danish Ministry of Health.

INNOVATIVE
SSI is innovative and provides the right solutions at the right time by being at the forefront of new technologies, performing world-class research, and continuously striving to perform our tasks and solve problems in the best and most efficient manner.

COLLABORATIVE
The best solutions are reached in close collaboration with those who benefit from SSI’s activities and with others who can complement SSI’s competencies. SSI collaborates and interacts with all relevant outside partners, as is reflected in our vision of being ‘an integrated part of the Danish and international healthcare services’.

Mads Melbye

Contact

Mads Melbye , President, CEO , Management board
T. +45 32683163 @. mme@ssi.dk View profile